The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota
Abstract
In the past decade, numerous studies have demonstrated the close relationship between gut microbiota and the occurrence and development of Alzheimer's disease (AD). However, the specific mechanism is still unclear. Both the neuroinflammation and systemic inflammation serve as the key hubs to accelerate the process of AD by promoting pathology and damaging neuron. What's more, the gut microbiota is also crucial for the regulation of inflammation. Therefore, this review focused on the role of gut microbiota in AD through inflammatory pathways. Firstly, this review summarized the relationship and interaction among gut microbiota, inflammation, and AD. Secondly, the direct and indirect regulatory effects of gut microbiota on AD through inflammatory pathways were described. These effects were mainly mediated by the component of the gut microbiota (lipopolysaccharides (LPS) and amyloid peptides), the metabolites of bacteria (short-chain fatty acids, branched amino acids, and neurotransmitters) and functional by-products (bile acids). In addition, potential treatments (fecal microbiota transplantation, antibiotics, probiotics, prebiotics, and dietary interventions) for AD were also discussed through these mechanisms. Finally, according to the current research status, the key problems to be solved in the future studies were proposed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This hypothesis posits that various pathological factors, such as Aβ plaques, pro-inflammatory cytokines, and oxidative stress, activate microglia, the central nervous system’s innate immune cells. Upon activation, microglia undergo morphological changes and initiate a variety of inflammatory responses, which can lead to the release of pro-inflammatory mediators that exacerbate neurotoxicity.”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [16]
In the citing paper
“The inflammatory hypothesis suggests that chronic neuroinflammation plays a significant role in the pathogenesis of AD.”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [16]
In the citing paper
“The persistent activation of microglia may result in a failure to resolve inflammation, contributing to neuronal damage and the cognitive decline associated with AD [15,16].”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [16]
Citations
Cites
Items 201–209 of 209
Dysfunction of Glutamate Receptors in Microglia May Cause Neurodegeneration
Noda, M. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666151116125810 · Cited by 34
Cervellati, C., Trentini, A., Bosi, C., Valacchi, G., Morieri, M. L., Zurlo, A., Brombo, G., Passaro, A., & Zuliani, G. (2018) · GeroScience · doi:10.1007/s11357-018-0010-6 · Cited by 32
Volpi, C., Mondanelli, G., Pallotta, M. T., Vacca, C., Iacono, A., Gargaro, M., Albini, E., Bianchi, R., Belladonna, M. L., Célanire, S., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.036 · Cited by 31
Walker, K. A., Windham, B. G., Brown, C. H., Knopman, D. S., Jack, C. R., Mosley, T. H., Selvin, E., Wong, D. F., Hughes, T. M., Zhou, Y., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180469 · Cited by 30
Nuydens, R., Heers, C., Chadarevian, A., de Jong, M., Nuyens, R., Cornelissen, F. W., & Geerts, H. (1995) · Brain Research · doi:10.1016/0006-8993(95)00514-q · Cited by 28
Chantong, B., Kratschmar, D. V., Lister, A., & Odermatt, A. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0190-7 · Cited by 28
Carvalho, T. G., Alves‐Silva, J., de Souza, J. M., Real, A. L. C. V., Doria, J. G., Vieira, É. L. M., Gomes, G. F., de Oliveira, A. C., de Miranda, A. S., & Ribeiro, F. M. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.03.020 · Cited by 28
Zhao, Y., Sharfman, N. M., Jaber, V. R., & Lukiw, W. J. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00314 · Cited by 28
Zhang, Y., Shao, H., Dong, Y., Swain, C. A., Yu, B., Xia, W., & Xie, Z. (2014) · Translational Neurodegeneration · doi:10.1186/2047-9158-3-8 · Cited by 24
Research works printed but not linked: 1
- van der Kant, 2020, Amyloid-β-independent regulators of tau pathology in Alzheimer disease. Nature reviews, Neuroscience, 21, 21
Cited by
Sorted by citations
Więckowska-Gacek, A., Mietelska-Porowska, A., Wydrych, M., & Wojda, U. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101397 · Cited by 343
Zhang, B., Chen, T., Cao, M., Yuan, C., Reiter, R. J., Zhao, Z., Zhao, Y., Chen, L., Fan, W., Wang, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.900132 · Cited by 80
Ullah, R., Park, T. J., Huang, X., & Kim, M. O. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101451 · Cited by 78
Qian, X.-H., Liu, X.-L., Chen, G., Chen, S.-D., & Tang, H.-D. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02599-4 · Cited by 56
Self-citationRecent Advances in Therapeutics for the Treatment of Alzheimer’s Disease
Thawabteh, A. M., Ghanem, A. W., AbuMadi, S., Thaher, D., Jaghama, W., Karaman, D., & Karaman, R. (2024) · Molecules · doi:10.3390/molecules29215131 · Cited by 56
“The persistent activation of microglia may result in a failure to resolve inflammation, contributing to neuronal damage and the cognitive decline associated with AD [15,16].”
Background
Metadata
- Authors
- Qian, X.-H., Song, X.-X., Liu, X.-L., Chen, S.-D., & Tang, H.-D.
- Venue
- Ageing Research Reviews
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 68
- Pages
- 101317
- ISSN
- 1568-1637 (ISSN-L)
- OpenAlex
- W3134448216
- Cited by
- 153
- References
- 209
- Citations by year
- 2026: 12 · 2025: 31 · 2024: 35 · 2023: 40 · 2022: 28 · 2021: 7
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Ageing Research Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, gut microbiota, neuroinflammation, systemic inflammation, lipopolysaccharide, amyloid peptides, short-chain fatty acids, branched-chain amino acids, neurotransmitters, bile acids, fecal microbiota transplantation, probiotics, prebiotics, dietary intervention, antibiotics
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Alzheimer Disease, Amyloid, Humans, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
